Amphetamine, mazindol, and fencamfamin in narcolepsy.
Twenty patients with the narcoleptic syndrome were treated separately with dexamphetamine sulphate tablets 10 and 30 mg, Dexedrine Spansules 10 mg, mazindol 4 mg, and fencamfamin hydrochloride 60 mg daily. Each drug was given for four weeks and the effects compared. In these dosages the reported frequency of attacks of narcolepsy was roughly halved with each treatment, dexamphetamine 30 mg daily being only slightly more potent than 10 mg. The subjective effects of Dexedrine tablets and Spansules could not be distinguished by most patients. Effects on mood, alertness, and sympathomimetic side effects were largely inseparable with all these drugs, but a decrease in appetite was not reported by patients with narcolepsy.
Shindler
J
J
Schachter
M
M
Brincat
S
S
Parkes
J D
JD
D000328:Adult; D000368:Aged; D000662:Amphetamines / Q000009:adverse effects / Q000627:therapeutic use*; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D008454:Mazindol / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009290:Narcolepsy / Q000188:drug therapy*; D009636:Norbornanes / Q000009:adverse effects / Q000627:therapeutic use*
D000662:Amphetamines; D000697:Central Nervous System Stimulants; D007211:Indoles; D009636:Norbornanes; D008454:Mazindol; C020900:fencamfamine